Ticker Short Interest

MED Short Interest Intelligence

MEDIFAST INC positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Bearish Exhaustion Watch

MED is classified as Neutral. Latest reported short interest is 1.6M shares; short interest changed -27.6%, price moved -11.6% since the previous report, short interest is in the 14th percentile, and days to cover is in the 14th percentile. Trend context is improving.

Setup Score40/100Neutral
Reported Short Interest1.6M-27.6% vs prior report
Days To Cover3.6914.29 percentile
Price Reaction-11.6%since previous short report
Squeeze Pressure21crowding, trend, and pressure
Bearish Conviction20shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

21

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

20

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

14

Latest short interest is 1.6M shares and days to cover is 3.69.

Divergence

40

Short interest fell while price fell. Shorts are covering despite weak price action, which can suggest the easy bearish pressure may be fading.

Report History

MED Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 1561657 2155853 -27.6% 3.69 423124
15 Jun 2026 2155853 2175625 -0.9% 15.34 140556
29 May 2026 2175625 2186673 -0.5% 10.16 214199
15 May 2026 2186673 2031979 7.6% 9.33 234277
30 Apr 2026 2031979 2164087 -6.1% 13.19 154047
15 Apr 2026 2164087 2055809 5.3% 9.29 232828
31 Mar 2026 2055809 2036788 0.9% 6.85 300284

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.